Freeze-dried rat bone marrow mesenchymal stem cell paracrine factors: A simplified novel material for skin wound therapy

Tissue Engineering - Part A

Volumn 21, Issue 5-6, 2015, Pages 1036-1046

  Peng, Yan ^a,b   Xuan, Min ^c   Zou, Jiping ^a   Liu, Hongwei ^d   Zhuo, Ziyuan ^a   Wan, Yu ^a   Cheng, Biao ^a  

^a GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

^d THE FIRST AFFILIATED HOSPITAL OF JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; CELL CULTURE; IMPLANTS (SURGICAL); MEDICINE; RATS; SCANNING ELECTRON MICROSCOPY; TISSUE REGENERATION; TOXICITY;

BONE MARROW MESENCHYMAL STEM CELLS; CLINICAL MEDICINE; CONDITIONED MEDIUM; DERMAL FIBROBLASTS; IMMUNOHISTOCHEMICAL STAINING; MESENCHYMAL STEM CELL; NEO-VASCULARIZATION; SCANNING ELECTRON MICROSCOPY IMAGE;

STEM CELLS;

ADIPOCYTOKINE; BIOMIMETIC MATERIAL; FREEZE DRIED BONE MARROW MESENCHYMAL STEM CELL CONDITIONED MEDIUM MEMBRANE; GROWTH FACTOR; INTERLEUKIN 6; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PARACRINE FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; SCATTER FACTOR; STROMAL CELL DERIVED FACTOR 1ALPHA; TISSUE CULTURE MEDIUM; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; BIOMATERIAL; CHEMOKINE; CULTURE MEDIUM; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; BIOSAFETY; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIZATION; FREEZE DRYING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; NANOFABRICATION; NONHUMAN; PLATELET-RICH PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCANNING ELECTRON MICROSCOPY; SKIN FIBROBLAST; SKIN INJURY; THERAPY EFFECT; TISSUE REPAIR; TOXICITY; WOUND CLOSURE; WOUND HEALING; ANGIOGENESIS; ANIMAL; BONE MARROW CELL; CULTURE MEDIUM; CYTOLOGY; DERMIS; DRUG EFFECTS; EPITHELIUM; FIBROBLAST; MESENCHYMAL STROMA CELL; METABOLISM; PARACRINE SIGNALING; PATHOLOGY; PHARMACOLOGY; SKIN; SPRAGUE DAWLEY RAT; VASCULARIZATION;

RATTUS;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOMIMETIC MATERIALS; BONE MARROW CELLS; CHEMOKINES; CULTURE MEDIA, CONDITIONED; DERMIS; EPITHELIUM; FIBROBLASTS; FREEZE DRYING; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STROMAL CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; PARACRINE COMMUNICATION; RATS, SPRAGUE-DAWLEY; SKIN; WOUND HEALING;

EID: 84924376328     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2014.0102     Document Type: Article

References (41)

1. Song, L., Baksh, D., and Tuan, R.S. Mesenchymal stem cell-based cartilage tissue engineering: cells, scaffold and biology. Cytotherapy 6, 596, 2004.
2. Nie, C., Zhang, G., Yang, D., Liu, T., Liu, D., Xu, J., et al. Targeted delivery of adipose-derived stem cells via acellular dermal matrix enhances wound repair in diabetic rats. J Tissue Eng Regen Med 2012. DOI: 10.1002/term.1622.
3. Shen, L., Zeng, W., Wu, Y.X., Hou, C.L., Chen, W., Yang, M.C., et al. Neurotrophin-3 accelerates wound healing in diabetic mice by promoting a paracrine response in mesenchymal stem cells. Cell Transplant 22, 1011, 2013.
4. Wilkins, R.G., and Unverdorben, M. Wound cleaning and wound healing: a concise review. Adv Skin Wound Care 26, 160, 2013.
5. Evsikov, A.V., and Solter, D. Comment on "'Stemness': transcriptional profiling of embryonic and adult stem cells" and "a stem cell molecular signature". Science 302, 393, 2003; author reply 393.
6. Ramalho-Santos, M., Yoon, S., Matsuzaki, Y., Mulligan, R.C., and Melton, D.A. "Stemness": transcriptional profiling of embryonic and adult stem cells. Science 298, 597, 2002.
7. Zhang, Q.Z., Su, W.R., Shi, S.H., Wilder-Smith, P., Xiang, A.P., Wong, A., et al. Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing. Stem Cells 28, 1856, 2010.
8. Buikema, J., van der Meer, P., Sluijter, J.P., and Domian, I.J. Engineering myocardial tissue: the convergence of stem cells biology and tissue engineering technology. Stem Cells 31, 2587, 2013.
9. Yu, B., Zhang, X., and Li, X. Exosomes derived from mesenchymal stem cells. Int J Mol Sci 15, 4142, 2014.
10. Du, Z., Wei, C., Cheng, K., Han, B., Yan, J., Zhang, M., et al. Mesenchymal stem cell-conditioned medium reduces liver injury and enhances regeneration in reduced-size rat liver transplantation. J Surg Res 183, 907, 2013.
11. Moghadasali, R., Mutsaers, H.A., Azarnia, M., Aghdami, N., Baharvand, H., Torensma, R., et al. Mesenchymal stem cell-conditioned medium accelerates regeneration of human renal proximal tubule epithelial cells after gentamicin toxicity. Exp Toxicol Pathol 65, 595, 2013.
12. Burdon, T.J., Paul, A., Noiseux, N., Prakash, S., and Shum-Tim, D. Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential. Bone Marrow Res 2011, 207326, 2011.
13. Ratajczak, M.Z., Kucia, M., Jadczyk, T., Greco, N.J., Wojakowski, W., Tendera, M., et al. Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies? Leukemia 26, 1166, 2012.
14. Afzal, M.R., Haider, H., Idris, N.M., Jiang, S., Ahmed, R.P., and Ashraf, M. Preconditioning promotes survival and angiomyogenic potential of mesenchymal stem cells in the infarcted heart via NF-kappaB signaling. Antioxid Redox Signal 12, 693, 2010.
15. Kamota, T., Li, T.S., Morikage, N., Murakami, M., Ohshima, M., Kubo, M., et al. Ischemic pre-conditioning enhances the mobilization and recruitment of bone marrow stem cells to protect against ischemia/reperfusion injury in the late phase. J Am Coll Cardiol 53, 1814, 2009.
16. Xing, Y., Lv, A., Wang, L., and Yan, X. The combination of angiotensin II and 5-azacytidine promotes cardiomyocyte differentiation of rat bone marrow mesenchymal stem cells. Mol Cell Biochem 360, 279, 2012.
17. Shi, R.Z., Wang, J.C., Huang, S.H., Wang, X.J., and Li, Q.P. Angiotensin II induces vascular endothelial growth factor synthesis in mesenchymal stem cells. Exp Cell Res 315, 10, 2009.
18. Tang, J., Wang, J., Guo, L., Kong, X., Yang, J., Zheng, F., et al. Mesenchymal stem cells modified with stromal cellderived factor 1 alpha improve cardiac remodeling via paracrine activation of hepatocyte growth factor in a rat model of myocardial infarction. Mol Cells 29, 9, 2010.
19. Patterson, T.E., Kumagai, K., Griffith, L., and Muschler, G.F. Cellular strategies for enhancement of fracture repair. J Bone Joint Surg Am 90 Suppl 1, 111, 2008.
20. Kloss, F.R., Gassner, R., Preiner, J., Ebner, A., Larsson, K., Hachl, O., et al. The role of oxygen termination of nanocrystalline diamond on immobilisation of BMP-2 and subsequent bone formation. Biomaterials 29, 2433, 2008.
21. Titmarsh, D.M., Hudson, J.E., Hidalgo, A., Elefanty, A.G., Stanley, E.G., Wolvetang, E.J., et al. Microbioreactor arrays for full factorial screening of exogenous and paracrine factors in human embryonic stem cell differentiation. PLoS One 7, e52405, 2012.
22. Pietramaggiori, G., Scherer, S.S., Mathews, J.C., Alperovich, M., Yang, H.J., Neuwalder, J., et al. Healing modulation induced by freeze-dried platelet-rich plasma and micronized allogenic dermis in a diabetic wound model. Wound Repair Regen 16, 218, 2008.
23. Pietramaggiori, G., Kaipainen, A., Czeczuga, J.M., Wagner, C.T., and Orgill, D.P. Freeze-dried platelet-rich plasma shows beneficial healing properties in chronic wounds. Wound Repair Regen 14, 573, 2006.
24. Nakajima, Y., Kawase, T., Kobayashi, M., Okuda, K., Wolff, L.F., and Yoshie, H. Bioactivity of freeze-dried platelet-rich plasma in an adsorbed form on a biodegradable polymer material. Platelets 23, 594, 2012.
25. Tropel, P., Noel, D., Platet, N., Legrand, P., Benabid, A.L., and Berger, F. Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow. Exp Cell Res 295, 395, 2004.
26. Kawase, T., Tanaka, T., Nishimoto, T., Okuda, K., Nagata, M., Burns, D.M., et al. Improved adhesion of human cultured periosteal sheets to a porous poly(L-lactic acid) membrane scaffold without the aid of exogenous adhesion biomolecules. J Biomed Mater Res A 98, 100, 2011.
27. Kawase, T., Okuda, K., Kogami, H., Nakayama, H., Nagata, M., Sato, T., et al. Human periosteum-derived cells combined with superporous hydroxyapatite blocks used as an osteogenic bone substitute for periodontal regenerative therapy: an animal implantation study using nude mice. J Periodontol 81, 420, 2010.
28. Nagaya, N., Fujii, T., Iwase, T., Ohgushi, H., Itoh, T., Uematsu, M., et al. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol 287, H2670, 2004.
29. Nagaya, N., Kangawa, K., Itoh, T., Iwase, T., Murakami, S., Miyahara, Y., et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112, 1128, 2005.
30. Kinnaird, T., Stabile, E., Burnett, M.S., Lee, C.W., Barr, S., Fuchs, S., et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94, 678, 2004.
31. Mastri, M., Lin, H., and Lee, T. Enhancing the efficacy of mesenchymal stem cell therapy. World J Stem Cells 6, 82, 2014.
32. Samper, E., Diez-Juan, A., Montero, J.A., and Sepulveda, P. Cardiac cell therapy: boosting mesenchymal stem cells effects. Stem Cell Rev 9, 266, 2013.
33. Lange, C., Togel, F., Ittrich, H., Clayton, F., Nolte-Ernsting, C., Zander, A.R., et al. Administered mesenchymal stem cells enhance recovery from ischemia/reperfusioninduced acute renal failure in rats. Kidney Int 68, 1613, 2005.
34. Rehman, J., Traktuev, D., Li, J., Merfeld-Clauss, S., Temm-Grove, C.J., Bovenkerk, J.E., et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109, 1292, 2004.
35. Chen, L., Tredget, E.E., Wu, P.Y., and Wu, Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 3, e1886, 2008.
36. Takahashi, M., Li, T.S., Suzuki, R., Kobayashi, T., Ito, H., Ikeda, Y., et al. Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. Am J Physiol Heart Circ Physiol 291, H886, 2006.
37. Chan, J.K., and Lam, P.Y. Human mesenchymal stem cells and their paracrine factors for the treatment of brain tumors. Cancer Gene Ther 20, 539, 2013.
38. Tam, K., Suganya, C., Venugopal, J., Biswas, A., Choolani, M., Ramakrishna, S., et al. A Nanoscaffold impregnated with human Wharton's jelly stem cells or its secretions improves healing of wounds. J Cell Biochem 115, 794, 2014.
39. Balogun, W.O., and Gureje, O. Self-reported incident type 2 diabetes in the Ibadan study of ageing: relationship with urban residence and socioeconomic status. Gerontology 59, 3, 2013.
40. Pijpers, E., Ferreira, I., de Jongh, R.T., Deeg, D.J., Lips, P., Stehouwer, C.D., et al. Older individuals with diabetes have an increased risk of recurrent falls: analysis of potential mediating factors: the Longitudinal Ageing Study Amsterdam. Age Ageing 41, 358, 2012.
41. Noale, M., Maggi, S., Zanoni, S., Limongi, F., Zambon, S., and Crepaldi, G. The metabolic syndrome, incidence of diabetes and mortality among the elderly: the Italian Longitudinal Study of Ageing. Diabetes Metab 38, 135, 2012.